BioWorld - Wednesday, February 4, 2026

BioWorld Science

Jan. 18, 2021

View Archived Issues

Discovery and characterization of specific inhibitors of human mitochondrial transcription

Read More

Cellular underpinnings of allergen immunotherapy success

Read More

F8-4-1BBL, a novel antibody-cytokine fusion protein with potent antitumor activity in vivo

Read More

Presenilin mutations affect neuronal stem cells

Read More

New causal gene for chronic kidney disease

Read More

Trying to stay ahead of SARS-CoV-2 as variants emerge

Read More

Overactive immunity can increase susceptibility to fungal infections

Read More

With partner in crime, MYC repairs DNA breaks

Read More

Interim data from phase II studies of novel combination immunotherapy in pancreatic cancer

Read More

ViGeneron and Daiichi Sankyo collaborate to evaluate vgAAV for novel ophthalmic gene therapy

Read More

FDA approves Enhertu for previously treated HER2-positive gastric or GEJ cancer

Read More

CCS-1477, novel p300/CBP inhibitor with promising activity in prostate cancer

Read More

Metrion and LifeArc extend neuroscience drug discovery collaboration

Read More

Nanjing Sanhome Pharmaceutical patents PRMT5 inhibitors

Read More

Dosing begins in phase IIa study of STP-705 for cutaneous basal cell carcinoma

Read More

FDA approves Darzalex Faspro for newly diagnosed light-chain amyloidosis

Read More

SinoMab initiates phase I trial in China with SN-1011 for autoimmune disease

Read More

Novel anti-mesothelin and anti-FucGM1 ADCs show promising antitumor activity in vivo

Read More

EdiGene obtains IND approval in China for ET-01 for transfusion dependent beta-thalassemia

Read More